139 related articles for article (PubMed ID: 3063912)
1. A murine monoclonal antibody against Klebsiella capsular polysaccharide is opsonic in vitro and protects against experimental Klebsiella pneumoniae infection.
Trautmann M; Cryz SJ; Sadoff JC; Cross AS
Microb Pathog; 1988 Sep; 5(3):177-87. PubMed ID: 3063912
[TBL] [Abstract][Full Text] [Related]
2. Novel, Broadly Reactive Anticapsular Antibodies against Carbapenem-Resistant Klebsiella pneumoniae Protect from Infection.
Diago-Navarro E; Motley MP; Ruiz-Peréz G; Yu W; Austin J; Seco BMS; Xiao G; Chikhalya A; Seeberger PH; Fries BC
mBio; 2018 Apr; 9(2):. PubMed ID: 29615497
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody against Klebsiella capsular polysaccharide reduces severity and hematogenic spread of experimental Klebsiella pneumoniae pneumonia.
Held TK; Trautmann M; Mielke ME; Neudeck H; Cryz SJ; Cross AS
Infect Immun; 1992 May; 60(5):1771-8. PubMed ID: 1563764
[TBL] [Abstract][Full Text] [Related]
4. The Role of IgG Subclass in Antibody-Mediated Protection against Carbapenem-Resistant Klebsiella pneumoniae.
Motley MP; Diago-Navarro E; Banerjee K; Inzerillo S; Fries BC
mBio; 2020 Sep; 11(5):. PubMed ID: 32900809
[TBL] [Abstract][Full Text] [Related]
5. Murine immunoprotective activity of Klebsiella pneumoniae cell surface preparations: comparative study with ribosomal preparations.
Fournier JM; Jolivet-Reynaud C; Riottot MM; Jouin H
Infect Immun; 1981 May; 32(2):420-6. PubMed ID: 7019071
[TBL] [Abstract][Full Text] [Related]
6. Capsular Polysaccharide Is Involved in NLRP3 Inflammasome Activation by Klebsiella pneumoniae Serotype K1.
Hua KF; Yang FL; Chiu HW; Chou JC; Dong WC; Lin CN; Lin CY; Wang JT; Li LH; Chiu HW; Chiu YC; Wu SH
Infect Immun; 2015 Sep; 83(9):3396-409. PubMed ID: 26077758
[TBL] [Abstract][Full Text] [Related]
7. Patient-Derived Antibody Data Yields Development of Broadly Cross-Protective Monoclonal Antibody against ST258 Carbapenem-Resistant
Banerjee K; Motley MP; Boniche-Alfaro C; Bhattacharya S; Shah R; Ardizzone A; Fries BC
Microbiol Spectr; 2022 Aug; 10(4):e0176022. PubMed ID: 35862974
[TBL] [Abstract][Full Text] [Related]
8. Production and partial characterization of monoclonal antibodies to Pasteurella haemolytica A1 capsular polysaccharide and lipopolysaccharide.
Penaredondo MV; Maheswaran SK; Whiteley LO; Ames TR; Leininger JR
Am J Vet Res; 1988 Nov; 49(11):1962-8. PubMed ID: 2470277
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of phagocytic-resistant capsular serotypes of Klebsiella pneumoniae in liver abscess.
Lin JC; Chang FY; Fung CP; Xu JZ; Cheng HP; Wang JJ; Huang LY; Siu LK
Microbes Infect; 2004 Nov; 6(13):1191-8. PubMed ID: 15488738
[TBL] [Abstract][Full Text] [Related]
10. Human monoclonal antibodies specific for capsular polysaccharides of Klebsiella recognize clusters of multiple serotypes.
Lang AB; Bruderer U; Senyk G; Pitt TL; Larrick JW; Cryz SJ
J Immunol; 1991 May; 146(9):3160-4. PubMed ID: 2016541
[TBL] [Abstract][Full Text] [Related]
11. Salicylate-enhanced exposure of Klebsiella pneumoniae subcapsular components.
Salo RJ; Domenico P; Tomás JM; Straus DC; Merino S; Benedí VJ; Cunha BA
Infection; 1995; 23(6):371-7. PubMed ID: 8655209
[TBL] [Abstract][Full Text] [Related]
12. Effect of capsular polysaccharide of Klebsiella pneumoniae on host resistance to bacterial infections. III. Further study of its effects on interactions between peritoneal leukocytes and virulent Salmonella enteritidis.
Kato N; Kato O; Nakashima I; Naito S; Asai J
Microbiol Immunol; 1979; 23(5):369-82. PubMed ID: 388155
[TBL] [Abstract][Full Text] [Related]
13. Direct evidence for the involvement of capsular polysaccharide in the immunoprotective activity of Klebsiella pneumoniae ribosomal preparations.
Riottot MM; Fournier JM; Jouin H
Infect Immun; 1981 Jan; 31(1):71-7. PubMed ID: 7012008
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of pneumococcal capsular polysaccharide-specific antibodies to serotype 3 Streptococcus pneumoniae requires macrophages.
Fabrizio K; Manix C; Tian H; van Rooijen N; Pirofski LA
Vaccine; 2010 Nov; 28(47):7542-50. PubMed ID: 20800700
[TBL] [Abstract][Full Text] [Related]
15. Immunization against fatal experimental Klebsiella pneumoniae pneumonia.
Cryz SJ; Fürer E; Germanier R
Infect Immun; 1986 Nov; 54(2):403-7. PubMed ID: 3533779
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of Klebsiella pneumoniae K1 capsular polysaccharide vaccine in humans.
Cryz SJ; Fürer E; Germanier R
J Infect Dis; 1985 Apr; 151(4):665-71. PubMed ID: 3882856
[TBL] [Abstract][Full Text] [Related]
17. Role of lipopolysaccharide and complement in susceptibility of Klebsiella pneumoniae to nonimmune serum.
Ciurana B; Tomás JM
Infect Immun; 1987 Nov; 55(11):2741-6. PubMed ID: 3312009
[TBL] [Abstract][Full Text] [Related]
18. Immunochemical properties of oligosaccharide-protein conjugates with Klebsiella-K2-specificity. II. Protective capacity of the conjugates and anti-conjugate antibodies against infection with Klebsiella pneumoniae 01:K2 in mice.
Geyer H; Schlecht S; Himmelspach K
Med Microbiol Immunol; 1982; 171(3):135-43. PubMed ID: 6186899
[TBL] [Abstract][Full Text] [Related]
19. Biosynthesis of Klebsiella K2 capsular polysaccharide in Escherichia coli HB101 requires the functions of rmpA and the chromosomal cps gene cluster of the virulent strain Klebsiella pneumoniae Chedid (O1:K2).
Arakawa Y; Ohta M; Wacharotayankun R; Mori M; Kido N; Ito H; Komatsu T; Sugiyama T; Kato N
Infect Immun; 1991 Jun; 59(6):2043-50. PubMed ID: 2037364
[TBL] [Abstract][Full Text] [Related]
20. Aggregation of Streptococcus pneumoniae by a pneumococcal capsular polysaccharide-specific human monoclonal IgM correlates with antibody efficacy in vivo.
Fabrizio K; Manix C; Guimaraes AJ; Nosanchuk JD; Pirofski LA
Clin Vaccine Immunol; 2010 May; 17(5):713-21. PubMed ID: 20200186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
